Crossmark

Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential cardioprotective mechanisms of vitamin D?

Crossref DOI link: https://doi.org/10.1186/s12986-022-00666-4

Published Online: 2022-04-29

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ozorowski, Mateusz https://orcid.org/0000-0003-3401-8738
Wiciński, Michał

Wróbel, Łukasz

Fajkiel-Madajczyk, Anna
License Information

Text and Data Mining valid from 2022-04-29

Version of Record valid from 2022-04-29
More Information

Article History

Received: 8 February 2022

Accepted: 20 April 2022

First Online: 29 April 2022

Declarations

:

: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Ethics Committee of Nicolaus Copernicus University Collegium Medicum (Approval Number KB48/2019 of 29.01.2019).

: Not applicable.

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below